Compounded Topical Drug Market Size to Climb $6.78 Bn in 2034
The compounded topical drug market is growing due to increasing skin disorders affecting 1.8 billion people, personalized medicine demands, and drug shortages. Compounding allows for tailored medications without allergens. Key trends include Medisca's acquisition of liposomal bases in May 2022 and the FDA's addition of new APIs for compounding. Calgary Co-op reported $1.3 million in sales in 2023, up $0.1 million from 2022.
Last Updated : 21 April 2026
Category: Therapeutic Area
Insight Code: 5317
Format: PDF / PPT / Excel